Precision BioSciences, Inc.DTILNASDAQ
Loading
R&D Expense Growth Under PressureDecelerating
Percentile Rank11
Studio
Year-over-Year Change

Year-over-year research & development expense growth

Percentile
P11
Within normal range
vs 5Y Ago
-0.5x
Contraction
Streak
2 yr
Consecutive declineDecelerating
PeriodValue
2025-9.04%
202411.59%
202315.73%
2022-59.98%
202117.52%
202018.98%
201982.65%
2018122.01%
2017123.29%
20160.00%